<p>Association between comorbidity (HIV or TB) and treatment outcome<sup><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0173744#t004fn001" target="_blank">#</a></sup>.</p
<div><p>Objective</p><p>To improve the treatment of MDR-TB and HIV co-infected patients, we investig...
Tuberculosis (TB) is a major global health concern and is responsible for significant morbidity and ...
TB/HIV co-infections and associated factors among patients on directly observed treatment short cour...
<p>Association between comorbidity (HIV or TB) and time from symptom onset to disease diagnosis<a hr...
Associations with loss to follow-up from TB treatment for the HIV positive cohort.</p
<p>Risk factors of unsuccessful (failure, death or lost to follow-up) DR-TB treatment outcome among ...
Globally, nearly 3% of the 38 million people living with HIV (PLHIV) died in 2018. Underlying comorb...
Demographic and clinical characteristics of TB-HIV co-infected patients and bivariable analysis show...
Background: In Sub-Saharan Africa, HIV endemic has substantially contributed to the increasing tuber...
Background: Tuberculosis (TB) and HIV co-infection causes a heavy burden on health care systems and ...
Introduction. The convergence of TB and HIV dual epidemics is a major public health challenge in Gha...
HIV has globally infected 37.9 million people, of which 23.3 million (62%) are on antiretroviral tre...
BackgroundTB patients co-infected with HIV have worse treatment outcomes than non-coinfected patient...
Abstract Background TB and HIV are the most prevalent communicable diseases of major public health i...
*<p>P-value for likelihood ratio test,</p><p><sup>₣</sup>Adjusted for sex, age, ART status and TB re...
<div><p>Objective</p><p>To improve the treatment of MDR-TB and HIV co-infected patients, we investig...
Tuberculosis (TB) is a major global health concern and is responsible for significant morbidity and ...
TB/HIV co-infections and associated factors among patients on directly observed treatment short cour...
<p>Association between comorbidity (HIV or TB) and time from symptom onset to disease diagnosis<a hr...
Associations with loss to follow-up from TB treatment for the HIV positive cohort.</p
<p>Risk factors of unsuccessful (failure, death or lost to follow-up) DR-TB treatment outcome among ...
Globally, nearly 3% of the 38 million people living with HIV (PLHIV) died in 2018. Underlying comorb...
Demographic and clinical characteristics of TB-HIV co-infected patients and bivariable analysis show...
Background: In Sub-Saharan Africa, HIV endemic has substantially contributed to the increasing tuber...
Background: Tuberculosis (TB) and HIV co-infection causes a heavy burden on health care systems and ...
Introduction. The convergence of TB and HIV dual epidemics is a major public health challenge in Gha...
HIV has globally infected 37.9 million people, of which 23.3 million (62%) are on antiretroviral tre...
BackgroundTB patients co-infected with HIV have worse treatment outcomes than non-coinfected patient...
Abstract Background TB and HIV are the most prevalent communicable diseases of major public health i...
*<p>P-value for likelihood ratio test,</p><p><sup>₣</sup>Adjusted for sex, age, ART status and TB re...
<div><p>Objective</p><p>To improve the treatment of MDR-TB and HIV co-infected patients, we investig...
Tuberculosis (TB) is a major global health concern and is responsible for significant morbidity and ...
TB/HIV co-infections and associated factors among patients on directly observed treatment short cour...
DOI
Add to ORKG